These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35884998)

  • 21. Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19.
    Sarif J; Raychaudhuri D; D'Rozario R; Bandopadhyay P; Singh P; Mehta P; Hoque MA; Sinha BP; Kushwaha M; Sahni S; Devi P; Chattopadhyay P; Paul SR; Ray Y; Chaudhuri K; Banerjee S; Majumdar D; Saha B; Sarkar BS; Bhattacharya P; Chatterjee S; Paul S; Ghosh P; Pandey R; Sengupta S; Ganguly D
    Front Immunol; 2021; 12():738093. PubMed ID: 34777349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology.
    Villar M; Urra JM; Rodríguez-Del-Río FJ; Artigas-Jerónimo S; Jiménez-Collados N; Ferreras-Colino E; Contreras M; de Mera IGF; Estrada-Peña A; Gortázar C; de la Fuente J
    Front Immunol; 2021; 12():730710. PubMed ID: 34566994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 pandemic: Insights into genetic susceptibility to SARS-CoV-2 and host genes implications on virus spread, disease severity and outcomes.
    Dastar S; Gharesouran J; Mortazavi D; Hosseinzadeh H; Kian SJ; Taheri M; Ghafouri-Fard S; Jamali E; Rezazadeh M
    Hum Antibodies; 2022; 30(1):1-14. PubMed ID: 34864654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individual COVID-19 disease trajectories revealed by plasma proteomics.
    Memon D; Barrio-Hernandez I; Beltrao P
    EMBO Mol Med; 2021 Aug; 13(8):e14532. PubMed ID: 34260159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning.
    Zeng X; Song X; Ma T; Pan X; Zhou Y; Hou Y; Zhang Z; Li K; Karypis G; Cheng F
    J Proteome Res; 2020 Nov; 19(11):4624-4636. PubMed ID: 32654489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BSG/CD147 and ACE2 receptors facilitate SARS-CoV-2 infection of human iPS cell-derived kidney podocytes.
    Kalejaiye TD; Bhattacharya R; Burt MA; Travieso T; Okafor AE; Mou X; Blasi M; Musah S
    bioRxiv; 2021 Nov; ():. PubMed ID: 34816259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms.
    Aileni M; Rohela GK; Jogam P; Soujanya S; Zhang B
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronavirus disease 2019 (COVID-19): latest developments in potential treatments.
    Hon KL; Leung KKY; Leung AK; Qian SY; Chan VP; Ip P; Wong IC
    Drugs Context; 2020; 9():. PubMed ID: 32655654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses.
    Giri R; Bhardwaj T; Shegane M; Gehi BR; Kumar P; Gadhave K; Oldfield CJ; Uversky VN
    Cell Mol Life Sci; 2021 Feb; 78(4):1655-1688. PubMed ID: 32712910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 and oncological disease.
    Šálek T; Slopovský J; Pörsök Š; Pazderová N; Mináriková Z; Zomborská E; Špánik B
    Klin Onkol; 2021; 34(3):211-219. PubMed ID: 34362259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics.
    Xu B; Lei Y; Ren X; Yin F; Wu W; Sun Y; Wang X; Sun Q; Yang X; Wang X; Zhang R; Li Z; Fang S; Liu J
    ACS Omega; 2021 Jul; 6(26):16826-16836. PubMed ID: 34250342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress in understanding COVID-19: insights from the omics approach.
    Lin B; Liu J; Liu Y; Qin X
    Crit Rev Clin Lab Sci; 2021 Jun; 58(4):242-252. PubMed ID: 33375876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 vaccine candidates and vaccine development platforms available worldwide.
    Duman N; ALzaidi Z; Aynekin B; Taskin D; Demirors B; Yildirim A; Sahin IO; Bilgili F; Turanli ET; Beccari T; Bertelli M; Dundar M
    J Pharm Anal; 2021 Dec; 11(6):675-682. PubMed ID: 34540318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19).
    Bennet BM; Wolf J; Laureano R; Sellers RS
    Toxicol Pathol; 2020 Oct; 48(7):800-809. PubMed ID: 32926660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma Proteomics Elucidated a Protein Signature in COVID-19 Patients with Comorbidities and Early-Diagnosis Biomarkers.
    Urbiola-Salvador V; Lima de Souza S; Macur K; Czaplewska P; Chen Z
    Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34750798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
    Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
    J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34637131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.